Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis

Mi, Z; Zhang, YS; Feng, ZC; Liu, JH; Wu, JM; Tan, HP; Ma, XQ; Liu, ZG; Rong, PF

Liu, ZG (通讯作者),Cent South Univ, Xiangya Hosp 3, Dept Infect Dis, Changsha, Peoples R China.;Rong, PF (通讯作者),Cent South Univ, Natl Hlth Commiss, Key Lab Biol Nanotechnol, Changsha, Peoples R China.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022; 50 (1): 301

Abstract

Aim PD-1/PD-L1 inhibitors in combination with CTLA-4 inhibitors are being tested in a number of ongoing clinical trials. As a result, it is critical t......

Full Text Link